Document is current
Any future updates will be listed below
-
Authors
Li, Xin
Mamouni, Kenza
Zhao, Rui
Bai, Lijuan
Chen, Yanhua
Wu, Yifei
Xie, Zhong-Ru
Sautto, Giuseppe A. https://orcid.org/0000-0002-0273-2235
Liu, Degang
Bowen, Nathan J.
Danaher, Alira
Li, Dehong
Cook, Nicholas
Grayson, Skylar
Zhu, Jedidiah
Coleman, Ilsa M.
Nelson, Peter S. https://orcid.org/0000-0002-5451-5726
Bao, Qichao
Zhou, Jia
Osunkoya, Adeboye O.
Kucuk, Omer
Gera, Lajos
Wu, Daqing https://orcid.org/0000-0001-9050-7793
- License Information
-
More Information
Article History
Received: 22 March 2024
Revised: 1 March 2025
Accepted: 21 March 2025
First Online: 19 April 2025
Competing interests
: Lajos Gera and Daqing Wu have intellectual property interests in GH501 and related compounds. Daqing Wu has ownership interests in MetCure Therapeutics LLC. Lajos Gera and Omer Kucuk provided consultation services to MetCure Therapeutics LLC. No potential conflicts of interest were disclosed by the other authors.
: The Institutional Animal Care and Use Committee (IACUC) at Augusta University approved the animal protocol (AUP# 2014-0626) used in this study. All animal procedures were subjected to National Institutes of Health guidelines.
: Not applicable.
